The Biosurveillance Analytics Resource Directory (BARD): Facilitating the Use of Epidemiological Models for Infectious Disease Surveillance by Margevicius, Kristen J et al.
RESEARCH ARTICLE
The Biosurveillance Analytics Resource
Directory (BARD): Facilitating the Use of
Epidemiological Models for Infectious
Disease Surveillance
Kristen J Margevicius1, Nicholas Generous1, Esteban Abeyta1, Ben Althouse2,
Howard Burkom3, Lauren Castro1, Ashlynn Daughton1, Sara Y. Del Valle1,
Geoffrey Fairchild1, James M. Hyman4, Richard Kiang5, Andrew P. Morse6,7, Carmen
M. Pancerella8, Laura Pullum9, Arvind Ramanathan9, Jeffrey Schlegelmilch10,
Aaron Scott11, Kirsten J Taylor-McCabe1, Alessandro Vespignani12, Alina Deshpande1*
1 Analytics, Intelligence and Technology Division, Los Alamos National Laboratory, Los Alamos, New
Mexico, United States of America, 2 Santa Fe Institute, Santa Fe, NewMexico, United States of America,
3 Johns Hopkins University-Applied Physics Laboratory, Laurel, Maryland, United States of America,
4 Department of Mathematics, Tulane University, New Orleans, Louisiana, United States of America,
5 National Aeronautics and Space Administration, Greenbelt, Maryland, United States of America,
6 Department of Geography and Planning, School of Environmental Sciences, University of Liverpool,
Liverpool, United Kingdom, 7 NIHR Health Protection Research Unit in Emerging and Zoonotic Infections,
Liverpool, United Kingdom, 8 Distributed Systems Research, Sandia National Laboratories, Livermore,
California, United States of America, 9 Oak Ridge National Laboratory, Oak Ridge, Tennessee, United
States of America, 10 National Center for Disaster Preparedness, The Earth Institute—Columbia University,
New York, New York, United States of America, 11 USDA APHIS Veterinary Services, Science, Technology,
and Analysis Services, Fort Collins, Colorado, United States of America, 12 Laboratory for the Modeling of
Biological and Socio-Technical Systems, Northeastern University, Boston, Massachusetts, United States of
America
*Deshpande_a@lanl.gov
Abstract
Epidemiological modeling for infectious disease is important for disease management and
its routine implementation needs to be facilitated through better description of models in an
operational context. A standardized model characterization process that allows selection or
making manual comparisons of available models and their results is currently lacking. A key
need is a universal framework to facilitate model description and understanding of its fea-
tures. Los Alamos National Laboratory (LANL) has developed a comprehensive framework
that can be used to characterize an infectious disease model in an operational context. The
framework was developed through a consensus among a panel of subject matter experts.
In this paper, we describe the framework, its application to model characterization, and the
development of the Biosurveillance Analytics Resource Directory (BARD; http://brd.
bsvgateway.org/brd/), to facilitate the rapid selection of operational models for specific
infectious/communicable diseases. We offer this framework and associated database to
stakeholders of the infectious disease modeling field as a tool for standardizing model
description and facilitating the use of epidemiological models.
PLOS ONE | DOI:10.1371/journal.pone.0146600 January 28, 2016 1 / 17
OPEN ACCESS
Citation: Margevicius KJ, Generous N, Abeyta E,
Althouse B, Burkom H, Castro L, et al. (2016) The
Biosurveillance Analytics Resource Directory
(BARD): Facilitating the Use of Epidemiological
Models for Infectious Disease Surveillance. PLoS
ONE 11(1): e0146600. doi:10.1371/journal.
pone.0146600
Editor: Julio Vera, University of Erlangen-
Nuremberg, GERMANY
Received: June 19, 2015
Accepted: December 18, 2015
Published: January 28, 2016
Copyright: © 2016 Margevicius et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
The prototype database of models can be accessed
at http://bard.lanl.gov/brd.
Funding: This project was funded by the Defense
Threat Reductions Agency – Joint Science and
Technology Office (Grant # CB10007, DTRA10027-
10845).
Competing Interests: The authors have declared
that no competing interests exist.
Introduction
While epidemiological modeling for infectious disease is a well-accepted technique for disease
management, many epidemiological models do not progress beyond a research study and are
not accepted as tools that can be used in an operational setting for infectious disease surveil-
lance. In this context, “operational” refers to the application of an epidemiological model to a
real-world event for decision support and can be used as a tool by experts and non-experts
alike. The term “model” covers three major types, risk mapping, disease dynamics and anomaly
detection. Transition of such models from one-off studies to practical tools is a significant
effort that occurs rarely. In addition, even if there are models that could be used in an opera-
tional setting, there is neither a standardized approach for describing or assessing models, nor
a universal lexicon of terms that allows models to be compared and down selected. To address
these challenges, Los Alamos National Laboratory (LANL) has developed a comprehensive
framework and lexicon for characterizing epidemiological models that can be used for infec-
tious disease prediction, forecasting and/or monitoring. Such a template could promote an
understanding of diverse models by various stakeholders (e.g., model developers, government
analysts, public health practitioners, and epidemiologists) with different preconceptions, back-
grounds, expertise, and needs, and can foster greater use of epidemiological models as tools in
infectious disease surveillance. We describe this framework and our rationale for its develop-
ment next.
Mathematical and computational models increase our understanding of how different sys-
tems function and allow the prediction of their response to modeled changes of concern. In
public health, models of infectious disease epidemiology are used for a variety of cases ranging
from health promotion and disease prevention to health care system design and operation [1].
When applied to the area of infectious disease management, epidemiological models can be
learning and planning tools, and can facilitate public health decision-making. Specifically,
models that generate information on how an infectious disease outbreak may either emerge or
unfold can provide enhanced situational awareness for decision makers, analysts, and public
health officials, and can therefore support prevention and/or mitigation activities. However,
instances of epidemiological model use for decision support are few, and adoption of models
has been very gradual and various opinions exist on its success [2, 3]. For example, 20 years
elapsed before models developed first by Ronald Ross and then George Macdonald were used
in the planning for control of malaria [4]. Foot and mouth disease only saw epidemiological
modeling used in an operational setting during the 2001 UK outbreak, and discussions of the
model’s impact on decision making for mitigating that outbreak have been contentious [5, 6].
The use of epidemiological models is often restricted to experts (model developers) and during
an unfolding infectious disease event, it is the experts that discuss findings and relay consensus
opinions to policy makers. While this strategy has worked and been praised in a number of
independent reports [7], mainstream and routine use of epidemiological models could be
implemented if the models could be transformed into operational tools that can be also used by
non-experts.
While the intention to apply epidemiological models for various decisions exists, increased
implementation faces several challenges. For example, the utility and extent of model applica-
tion varies greatly depending on the disease of interest and the operational setting. Addition-
ally, actual implementation of the models and policies developed from the model results is not
guaranteed [8]. One potential exception to this is influenza because epidemiological models
have been used for various aspects of both planning and consequence management of this dis-
ease. [9–15].
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There exists a plethora of research studies [16] in the literature describing various epidemio-
logical models for infectious disease. However, limited use of these in an operational setting
thus far may be due to a lack of accessibility to such models, a limited availability of web-acces-
sible models, and a lack of plug and play types of models. In addition, there are two other spe-
cific challenges to integrating epidemiological models into operational biosurveillance that are
rarely considered:
1. Determining the operational context of a model
Choosing a useful epidemiological model for a given outbreak type is impossible without
knowledge of context and level of pre-operational development and testing [16], that is, with-
out a geographic or population scale of application and/or an understanding of available data
and other information sources, it is very difficult to determine what epidemiological model is
appropriate to use or whether a particular model is readily available for use. Moreover, beyond
having a graphical user interface (GUI) or web accessible interface, the components that make
a model “operational” are yet to be well defined. Such components must resolve basic questions
like:
• What is the purpose of the model? What decisions is the model designed to support?
• What surveillance goal does the model address?
• Is the model currently in use? If so, how, where, and by whom?
• Has the model been verified and validated?
• For which regions of the world does the model apply?
• What data inputs and data streams are required to generate a prediction or forecast?
• What computational infrastructure and resources are required to run the model?
• Can the model’s capability be extended to include a new disease and/or location?
These are all relevant questions that are infrequently answered in the literature. Without
answers to these questions, the selection of a context-appropriate model is impossible.
2. A lack of consistent model characterization schema that allows a user
to make an appropriate manual comparison of available models
Given the diversity of model types and the manner in which they are described, the selection of
an appropriate model is also a challenge. As an illustration of this challenge, consider the web-
sites for the North American Animal Disease Spread Model [17] and EpiMAN-FMD [18].
Both are generic “operational” platforms focusing on livestock disease. However, the two plat-
forms are described very differently even though the underlying model structure is similar. A
non-expert in modeling would find it difficult to make a choice between these platforms pri-
marily because they are not described in a common framework using a common lexicon.
Underlying techniques and uses of models are often interchangeably used to describe models.
For example, “risk mapping” and “hot spot mapping” are often used interchangeably to iden-
tify a model type, though risk mapping is a type of model [16] while hot spot mapping is a tech-
nique applied to identify a risk area.
There are ongoing efforts by public health stakeholders in government, academia, and
industry to increase the use of epidemiological models in infectious disease management. For
example, to increase use of predictive modeling of epidemic emergence for public health pre-
paredness, requirements for effective, sustainable models are provided by the Centers for
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Disease Control’s (CDC) Framework for Preventing Infectious Diseases [19]. The National
Operational Epidemiological Modeling Process (NOEMP) is a set of guidelines proposed by
Lenart et al. [2] to support improved information management in a health emergency or dis-
ease outbreak. One of the proposed functions of NOEMP is that this framework “enhances the
use of models during an operational response, including sharing models and model outputs
within and between agencies/organizations”. While these efforts are a first step towards bring-
ing epidemiological models into mainstream operational surveillance of disease, standards are
required to facilitate their use and acceptance. For instance, the definition of “operational” itself
can depend on who the targeted users of models are, the specific use, and the technical skills of
the users. Thus, a key need is a universal framework to facilitate model description and an
understanding of its features; development of such a framework and the associated database is
the primary goal of the work presented in this paper.
LANL developed a comprehensive framework to facilitate characterization of infectious dis-
ease models in an operational context and facilitate manual model comparison. The framework
was developed through a consensus among a panel of subject matter experts that included both
model developers, model users and decision makers. In this paper, we describe the framework,
its application to model characterization and the development of a web-based directory, the
Biosurveillance Analytics Resource Directory (BARD), to facilitate the rapid selection of opera-
tional models for specific infectious/communicable diseases. We offer this framework and
database to the stakeholders of the infectious disease modeling field as a tool for standardizing
model description and thus enhance the use and development of infectious disease models in
operational settings. One of the objectives of the model characterization framework is to
encourage model developers to start thinking and describing the many features of their models
using a common format. We illustrate the application of the framework through the develop-
ment of the BARD which is a scientific and non-biased tool for selecting an appropriate epide-
miological model for infectious disease surveillance.
Materials and Methods
To develop a conceptual framework for characterizing models used for operational disease pre-
diction, forecasting, and monitoring we collected information via a three-step process: a litera-
ture search of modeling characteristics, a review of current operational infectious disease
epidemiological models, and subject matter expert (SME) panel consultation.
A literature search was conducted to inform us about terms used by infectious disease
model developers and researchers to characterize their models. The purpose of the literature
search was not to provide a comprehensive review of modeling terms, but rather to understand
modeling terms, how they were used in the field, and the discrepancies or redundancies in
meaning found in the term’s usage. Multiple sources from a variety of modeling fields were
consulted including ones outside of infectious disease modeling like book chapters, conference
proceedings, peer-reviewed literature, reports found through traditional database searching
(e.g., Web of Knowledge, Google Scholar), as well as textbooks and model websites. The search
was intended to seek out the broad spectrum of vocabulary used in published literature related
to infectious disease modeling or to modeling approaches in general. Definitions, descriptions,
and operational context terms were tabulated and cross-referenced to develop common termi-
nology and were collated into a preliminary framework to describe and compare models.
A process similar to our literature search was followed to identify relevant infectious disease
models and to evaluate the effectiveness of the framework in characterizing models. We limited
the initial selection of models to five infectious diseases: influenza, malaria, dengue, cholera
and foot-and-mouth disease (FMD). These diseases capture a variety of transmission modes
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(human-to-human, vector-mediated, environmental exposure), represent high or potentially
high epidemic or endemic burden, and are well represented in the literature. Models were iden-
tified through web searches, literature searches (similar to above), and information provided
by our SME panel. Our team also developed working criteria (Table 1) for what attributes can
be used to comprehensively describe an operational model. These factors, described in Table 1,
include consideration of a model’s documentation, accessibility, and sustainability and are
listed in decreasing order of maturity.
A subject matter expert panel was assembled that included model developers, decision mak-
ers, and analysts with expertise and/or experience in the use or development of epidemiological
models for decision-making. Experts were selected by our team on the basis of their demon-
strated expertise (publications or technical presentations) within the subject matter of the use
or development of epidemiological models for decision-making, or on the recommendation of
an expert. The panelists consisted mostly of experts from the United States who work in acade-
mia or government; however, there were a few experts from other nations and industry.
Table 2 includes information regarding our SME panel.
The SME panel had three purposes: 1) to provide information on modeling terms and their
usage, 2) to provide the names and information of relevant infectious disease epidemiological
models, and 3) to provide feedback on the model characterization framework and the resultant
tool, the BARD. The panelists were provided with a document that described the modeling
terms and definitions, and model characterization framework as well as questions regarding
the functionality and usability of the BARD. Additionally, each panelist attended a
Table 1. Working Criteria for “Operational”Models.
Model Documentation Model Association Model Distribution
Model has the equivalent to a
‘user manual’
Model is currently in use and is being actively promoted for use by
others
Model code/software is readily available either
by open-source, by subscription/registration, or
by purchase
Model has technical
documentation
Model is linked to a website speciﬁc to the model Model code/software is available for distribution
for limited use
Model has been only described
in peer-reviewed literature
Model is only linked to a research group through documentation
(such as research team from a university that has published an
article describing results)
Model code/software is not accessible/available
doi:10.1371/journal.pone.0146600.t001
Table 2. SME Representation.
Total attended
demonstrations:
29 SMEs
Afﬁliation Representation:
Academia (10) John’s Hopkins University Bloomberg School of Public Health, John’s
Hopkins University Applied Physics Laboratory, University of Kansas
Lawrence, Northeastern University, The Santa Fe Institute, Tulane,
University of California Davis, University of Liverpool, University of
Maryland, Virginia Tech Virginia Bioinformatics Institute, Yale
Industry (1) IBM
Government Agency (7) Centers for Disease Control, Department of Homeland Security (DHS),
DHS/National Biosurveillance Integration Center, Defense Threat Reduction
Agency, DHS-Foreign Animal Zoonotic Diseases, National Aeronautics and
Space Agency, National Surveillance Unit, United States Department of
Agriculture (USDA)
National Laboratory (4) Los Alamos National Laboratory, Sandia National Laboratory, Oak Ridge
National Laboratory, Paciﬁc Northwest National Laboratory
doi:10.1371/journal.pone.0146600.t002
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teleconference and video demonstration of the BARD. The panelists provided oral and written
feedback on the BARD and the characterization framework. Based on SME feedback the terms
and definitions, characterization framework, and database tool were refined. The updated char-
acterization framework was provided to the SMEs for a second written evaluation.
Formalization of model characterization framework, terms and definitions–It is important
to note that this project is a first effort towards making model descriptions standardized, and
terms and definitions for the framework were derived through numerous sources described in
the paragraphs above, and vetted with the SME panel. This was an iterative process that took
several months and the framework and glossary (S1 File) underwent refinement following each
teleconference, e.mail notification and video demonstration. The final products shown in this
paper are consensus definitions which cannot be seen as “formalized” until official entities
such as MIDAS (Models of Infectious Disease Agent Study; http://www.nigms.nih.gov/
Research/SpecificAreas/MIDAS/Pages/default.aspx) are willing to adopt and promote their
usage. This paper is a means of starting this dialogue and spreading the word in the global epi-
demiological modeling community.
Only contact and affiliation information was collected about the individual SME responding
to the questionnaire, and the survey was strictly a means to record expert opinion. Therefore,
the SME panel survey did not involve human subjects research, and institutional review of the
survey was deemed unnecessary (Common Rule (45 CFR 46), LANL Human Subjects Research
Review Board (HSRRB)).
To apply the model characterization framework, we built a searchable relational database.
This database, the BARD, is currently a prototype but is publicly available (http://brd.
bsvgateway.org/brd/). The database is not necessary to replicate the findings from our study,
but is meant to demonstrate the utility of our framework. BARD is meant to be a searchable
reference of epidemiological models. The models, modeling terms, and systems described are
current as of June 2015. Descriptions of terms exist in words, but have not yet been formalised
as computer readable terms. Many of the terms could be linked to terms in existing ontologies
such as those available in Bioportal (http://bioportal.bioontology.org/) thus allowing the link-
age of multiple resources. This can be an added advantage for epidemiological models included
in an open repository such as the BARD. Categories in the BARD are based on the model char-
acterization framework and aim to capture all relevant information about epidemiological
models. The database schema is based on our model characterization framework that has been
explicitly described in Supplement 1 (S1 File; Model glossary) and shown in Fig 1 (Fig 1). The
schema includes categories, and associated terms which are also defined in the Model Glossary.
A document was also developed to describe the usability requirements for the BARD; that is,
potential users (and non-users) are formally described in order to elucidate how the BARD will
be utilized (S2 File). The document allows a reader to understand the specific types of users
that will benefit from the use of the BARD and the functions/tasks it will facilitate. It does not
include information on technical implementation (e.g., whether specific information is con-
tained in the database or pulled on demand from other sources). It also avoids specific design
ideas (such as widget descriptions) unless they are necessary to illustrate a specific
requirement.
To characterize the models using the framework, we did a literature search for papers and
technical documentation. We also searched for websites that host the models. Two separate
members of our team went through documentation of the model and assigned properties to
each of them. Properties for which the assignments agreed were entered into the BARD. The
model developers were then contacted and asked to fill in properties for fields for which the
assignments did not agree or the documentation was not sufficiently detailed. Model
BARD - A Database for Epidemiological Models
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developers were also asked to verify the accuracy of the information included in the BARD for
their models.
Results
Framework for model characterization
LANL developed a framework for systematically characterizing epidemiological models
applied to infectious disease surveillance that could be used for selecting such models in an
operational setting as well as making manual comparisons between similar models at a high
level. The framework and the BARD can be used by model developers to both describe their
models and offer them to decision makers for operational use. The BARD can also be used by
analysts and decision makers to rapidly select models during the planning or response of a real
world biological event. The framework was scoped by the core functions outlined in the
National Strategy for Biosurveillance [20] with the intention to facilitate better decision-
Fig 1. Model characterization framework that includes 6major components.
doi:10.1371/journal.pone.0146600.g001
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making. A more detailed description of the biosurveillance context (goals and data sources)
can be found in Margevicius et al. [21]. Themodeling framework (Fig 1) enables models to be
characterized not only by the mathematical constructs underpinning their application but also
by scope and operational utility.
The framework is divided into six major components: Model Purpose, Model Objective,
Model Scope, Biosurveillance (BSV) goals, Conceptual Model and Model Utility; each of which
has several sub-categories for characterizing each aspect of a model. For each of these compo-
nents, a list of terms and definitions has been compiled, the full detail of which is available in
S1 File.
1. Model Purpose describes the specific function of the model and the question it is
addressing; e.g. disease prediction or forecasting, assessment, monitoring or detection. While
“prediction” and “forecasting” have been used interchangeably as a description of the type of
model being used within a paper, we define prediction as the probability that a disease outbreak
will occur at a given time or location and forecasting as the projection of the extent, duration,
and/or magnitude of an ongoing disease outbreak ([16] S1 File).
2. Model Objective describes the specific reason for developing and implementing the
model such as planning for a vaccination strategy or predicting case incidence.
3.Model Scope identifies the specific location or disease for which the model has been
designed and whether the model is a general platform that is configurable for different diseases
and locations.
4. BSV Goals refer to the specific biosurveillance goals developed by LANL that cover the
entire time spectrum of biosurveillance from pre-event warning and detection to consequence
management [20]. This component, together with Model Utility (described as component 6
below), allows for a model to be considered in the context for which it has been developed and
for which it might be used.
5. Conceptual Model characterizes how a model predicts, forecasts, or monitors and
describes aspects such as the mathematical framework used, the model inputs and outputs and
the modeling techniques. Disparate types of models that are variously described in the litera-
ture can be easily distinguished; e.g., risk mapping, anomaly detection, and equation- and sim-
ulation-based disease dynamics models. By using the term Conceptual Model, the overall
approach of the model can be described and separated from the details associated with the
operational aspects of the model. This component also includes sub-categories to capture spe-
cific information on tools used by the model, the purpose of the tools, inputs and outputs of
the model, and assumptions and limitations of the model (S1 File). Categories like assumptions
and limitations for a model can have very diverse content, and rather than providing a drop
down list with fixed vocabulary, we allow free form text entry as is illustrated in Table 3. Essen-
tially, these fields are a means of offering the user as much information on the models so that
they can make an informed decision. It may not be possible to do an “apples to apples” com-
parison using one or more singular categories, but the hope is that the overall description using
this framework provides a first step in that direction.
Often, a disease model is used along with other models that evaluate risk or perform cost-
benefit analyses to achieve a particular objective (e.g., ensemble models that link risk mapping
or disease dynamics with economic models). While the specifics of these “hybrid”model types
are not completely characterized, the Conceptual Model framework component articulates the
use of each model type in a hybrid. This component also explicitly categorizes model tools,
inputs, outputs, assumptions and limitations such that through precision of terminology, com-
monality or differences in these features among can be identified.
6. Model Utility describes various operational features of a model such as the type of data it
may use, whether it has been validated and verified, the level of readiness for decision support
BARD - A Database for Epidemiological Models
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Table 3. Framework Use Cases.
Risk Mapping Anomaly Detection Disease Dynamics
Liverpool Malaria Model 2010 SaTScan EpiSimdemics
Purpose Forecasting Detection Assessment (Situation Assessment,
Planning and counterfactual analysis)
Objective Predict expected disease cases Inform disease process—Identify disease
cluster
Policy planning and course of action
analysis
Scope Speciﬁc disease Application Platform Platform
BSV Goals Early warning (EW), Early detection
(ED)
ED, Situational Awareness (SA) SA, Consequence Management (CM)
Conceptual Model
Model Type Disease dynamics Anomaly detection, Poisson based; Bernoulli
model
Disease dynamics
Model Tools
/Purpose of tools
Epidemic, SEIR model/ movement
between disease states
Statistical/ Determination of signiﬁcant
clusters in space or in space and time
(Threshold detection)
Epidemic, SEIR model/movement between
disease states
Model Inputs Disease, Epidemiological; Vector;
Environmental, Climate
Disease, Epidemiological; Environment,
Geography; Host Population, Demographics
Control Efforts; Disease, Epidemiological
Model Outputs Disease incidence, Epidemic spread Disease incidence Control effort effectiveness, Disease
incidence, Epidemic spread
Model Structure Compartmental model,
developmental degree days
N/A A general ﬁnite-state machine, or
probabilistic, timed transition system
Assumptions Uses literature based parameter
settings
Number of events in a geographical area is
Poisson-distributed
Not clearly delineated
Limitations Broad scale no local land use
conditions
The class of diseases; cannot be applied
to vector disease epidemiology
Model Utility
Data
Data Sources
Required
Daily temperature, Rainfall, vector
life cycle
Depends on speciﬁc application (can be
clinic/health provider records, lab records,
ED/hospital records, established databases)
Established databases (US census,
NAVTEQ street data, databases for non-
housing locations, school, and activity
data)
Data Availability Good from modeled data sets i.e.,
reanalysis or forecast/climate model
archives
Good
Documentation Yes Yes Yes
V&V
Veriﬁcation Yes Yes Yes
Validation Yes, Using a clinical diagnosis
based malaria index 20 years + from
Botswana
Validated with Ground-truth data Used by Federal agencies for pandemic
planning
Sensitivity Analysis Yes Unknown Yes
Uncertainty Normally run with multiple driving
data (climate) sets to encompass
some of the uncertainty.
Uncertainty clearly documented Not documented
Documentation Yes Yes Yes
Operations
Developer Team
Accessibility
Model team still active Unknown Model team still active
Funding Currently funded Currently funded Currently funded
Extensibility By disease and location By disease and location By disease and location
Source code /
hardware
availability
No, but desktop version available No Yes upon request
(Continued)
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(e.g. run time, accessibility, hardware platform, computational time, etc.). This component of
the framework was created to help determine whether a model may be rescaled or otherwise
modified for a context (e.g., disease type, location, output product) beyond that for which it
was designed. This component also assesses required development stages for modification and
implementation; i.e., Data, Verification and Validation, and Operations. The usefulness of a
model in decision making may rely heavily on factors such as data availability and the availabil-
ity of the model design team to assist in assuring appropriate and relevant model use. Having
the model utility information characterized alongside the more technical aspects of a model
supports decision making both in research and in operational settings.
Application to model characterization
Models for five infectious diseases—cholera, malaria, influenza, FMD and dengue were charac-
terized using the framework and are included in the BARD database. A total of 53 models were
characterized and include epidemiological models that predict, forecast or monitor these dis-
eases. The models were selected using the criteria described in the Methods section. The char-
acterization of models illustrating the three primary model types in our framework (risk
mapping, anomaly detection and disease dynamics) is shown in Table 3. Three models—the
Liverpool Malaria Model] LMM, [22], SaTScan [23], and EpiSimdemics [24] were selected as
examples to illustrate our characterization framework in this paper. Availability of detailed
information for these models in the reviewed literature as well as the ability to easily contact
the model developers were criteria used for this selection.
Our framework characterizes disparate models in a streamlined fashion as all model infor-
mation may be binned into the same categories, allowing easy manual comparison and under-
standing of the models. For the three models, four of the six components (Purpose, Objective,
Scope, and BSV Goals) were fairly straightforward to describe. However, Conceptual Model
and Model Utility components had to be further divided into several sub-categories to best cap-
ture finer details as shown in Table 3 and S1 File. In the Model Utility component these include
Model Type, Tools, Inputs, Outputs, while the Model Utility component sub categories include
Data Sources, Documentation, Verification and Validation. Within these numerous sub cate-
gories, we aimed to stay at a higher level of information description to facilitate both informa-
tion understanding as well as input. For example, under the “Model Inputs” sub-category, for
the model EpiSimdemics, description was limited to “control efforts” rather than a detailed list
of exactly what kinds of control efforts specifically used. Similarly, a model input “demograph-
ics” for SaTScan is sufficient to inform the reader without the need for specific details on the
various types of demographics used. However, details for each sub-category are made available
in the BARD.
Specific definitions for each category used in the framework also facilitated input of appro-
priate model information. For example the term “Verification” is defined in our Glossary as
Table 3. (Continued)
Risk Mapping Anomaly Detection Disease Dynamics
Liverpool Malaria Model 2010 SaTScan EpiSimdemics
Computational
requirements
Low (desktop) Low (desktop) High (super-computer)
Cost to implement Software is free Software is Free Unknown
Documentation A tutorial and training data set is
included in the desktop version
User manual available Not available
doi:10.1371/journal.pone.0146600.t003
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“conceptual model has been adequately translated into formula or computer code and per-
forms as intended—no coding or logic errors”. Validation, on the other hand, can occur
through different means (comparison with other models, comparison of model with real sys-
tem, model tested outside of developer team), any of which would result in a “yes” to address
that sub-category of model information.
Certain fields required in our framework were often omitted within model documentation.
In particular, the sub categories of model limitations and assumptions (under the Conceptual
Model component) were often not explicitly described or discussed in adequate detail. Addi-
tionally, many operationally-relevant details such as the source code language and availability,
computational and operating system requirements, verification and validation (V&V), and the
time it may take for a model to be adapted to a different disease or location were often not dis-
cussed. While this aspect is understandable since much of the documentation were academic
papers, for models to be used in operational settings, these types of details need to be included
in the model characterization/categorization.
Development of the BARD
The BARD is a decision support tool that can be used to search for and rapidly select appropri-
ate, epidemiological models that may predict, forecast or monitor infectious diseases. Rather
than being a conceptual classification scheme, our model characterization framework is imple-
mented in this actionable tool currently in prototype stage. The BARD provides specific infor-
mation about a model that has been systematically categorized and will offer precision through
its search and find function that is not available if one were to perform a standard Internet
search. The BARD allows manual category-to-category comparison of multiple models in sup-
port of a single disease and provides links to specific models with updated and accurate contact
information for each model facilitating its immediate use. The tool can also be used to charac-
terize new models that may be included in the future. The BARD was built as a resource to effi-
ciently obtain and retain specific information about each model, as characterized by the model
framework. It is important to note that the BARD is not a tool to rank models but rather a
source of model information that is easily available to a user in a format that allows the user to
make a ranking or an assessment of the utility of the model. It does not evaluate or verify the
accuracy of the models as that is a much larger effort and beyond the scope of the current proj-
ect. Thus, the BARD does not guarantee the accuracy of the models included in it, but does
provide information about whether the particular model has been verified and validated by the
developer or an independent entity.
To facilitate a first pass in finding models that could be considered useful in an operational
setting for each of the five specific diseases and included in the BARD, we sought models that
met the criteria described in the Methods section. Note that for the five diseases being included
in the prototype BARD, only a small percentage of models among those for which information
was collected met these criteria for being operationally mature (Table 4). These constitute mod-
els that have been transformed into tools for decision support. A second tier of models was
included into the BARD if they had unique model purpose or technique but were not necessar-
ily mature as tools.
Table 4. Models included in the BARD.
Number of Models Inﬂuenza Cholera Dengue FMD Malaria
Described Research Papers 109 30 22 81 34
Included in BARD 13 11 10 15 4
doi:10.1371/journal.pone.0146600.t004
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The results of our initial compilation and characterization of models for cholera, dengue,
FMD, influenza, and malaria in the BARD shows the usefulness of the characterization frame-
work in providing relevant information to an analyst or practitioner in selecting models in an
operational situation. The results may reflect the bias of our team's discovery efforts, and deter-
mination of which models to include in the BARD. However, a next stage in the development
of the BARD is to include a web-based, user interface for the BARD that would allow users of
the BARD to create, edit and provide feedback on content and functionality as well as to main-
tain curated information in this database through a community driven effort.
Fig 2 shows the distribution of models in the BARD developed for a particular biosurveil-
lance goal (early warning, early detection, situational awareness, consequence management)
for a specific disease. Other than models for dengue, and perhaps cholera, more models are
available further along the timeline of biosurveillance (i.e., for situational awareness and conse-
quence management) than for early warning or early detection. Such a form of searching
reveals surveillance goals for which model development could be directed.
For all diseases, the most represented model type (risk mapping, anomaly detection, disease
dynamics) was a dynamical model of disease transmission (Fig 3). This holds true even when
looking at only those models that have been transformed into decision support tools. Anomaly
detection models are often closely linked to disease surveillance systems and are not necessarily
called out as separate models. For example ESSENCE is an anomaly detection tool that is
Fig 2. BARDmodels developed for a particular biosurveillance goal for a specific disease
doi:10.1371/journal.pone.0146600.g002
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already operational and associated with several US state surveillance systems (e.g., ESSENCE-
Florida, [25]). This may be the reason why anomaly detection models were not well
represented.
Discussion
Mathematical modeling and simulation are potentially powerful tools that are becoming
increasingly important for public health decision-making and disease prevention strategy and
policy. However, models are not necessarily being developed with decision makers in mind.
This gap between model developers and decision makers needs to be narrowed before model-
ing becomes routinely used to inform decision makers during biological events. The gap is
reflected by the difference in the modeling numerous models and modeling techniques pub-
lished each year and the small number of these which have been used operationally. Of those
few that have been deployed in operational capacities, an even smaller number are described in
enough detail and with specific guidelines describing their operational characteristics, verifica-
tion and validation information, technical documentation, readiness and utility. To further
Fig 3. Types of models in the BARD
doi:10.1371/journal.pone.0146600.g003
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encourage model use in rapid decision making, they must be transformed into tools that can be
also used by non-experts in the field of modeling and simulation.
The persistent gap between developed and operationally ready models is not the fault of any
single party, but rather is a consequence of a complex situation involving multiple types of
institutions and jurisdictional levels with disparate goals amid a changing infectious disease
environment, with goals swinging between bioterrorism prevention and the routine needs of
public health surveillance. Front line health monitors have had little influence on the selection
and development of analytical methods. Model developers are not provided with guidance (or
funding) that addresses what under-resourced front line public health practitioners operation-
ally need from their model as well as characterization of their diverse and often ill-defined situ-
ational awareness needs. Moreover, Academia itself doesn’t reward developing operational
models, it rewards publishing papers. Funding for advanced analytic and surveillance capabili-
ties, especially at the local level where surveillance is often practiced, is ephemeral when avail-
able at all. More often than not, local government public health organizations struggle to find
the funding to meet basic services in their jurisdictions, let alone develop advanced analytical
and surveillance capability.
The characterization framework and the resultant tool developed—the BARD—represent a
first step towards working to solve these problems. They offer the initial steps of an infectious
disease epidemiological model ontology that can be understood and used by stakeholders who
may not have a modeling background. Our tool will be a significant step in bringing many
models out of the purely academic realm and into an operational setting as it describes models
in a standardized and structured fashion, with a common lexicon of terms. There are several
efforts underway in different communities to do this (e.g., biological process models, ecology,
[26–29]) and a similar initiative is required for epidemiological models used for infectious dis-
ease surveillance.
Key features of these efforts have been the development of standardized model repositories
such as the Biomodels database maintained by the European Bioinformatics Institute, and the
development of a centralized repository of relevant biological ontologies (http://obofoundry.
org) that can be referenced in the biological community. Together these initiatives contribute
to a standardized process by which biological pathways and processes are modelled, described
and understood. Systems biology standards are commonly developed under the umbrella of
the Computational Network for modeling in Biology, COMBINE (http://co.mbine.org).
The Biomodels database houses models developed for biological processes and pathways
that can be downloaded by users (https://www.ebi.ac.uk/biomodels-main/). There are two
main differences between the BARD and the Biomodels database;
1) The BARD only serves as a repository of information about epidemiological models that
have been described using a common lexicon of terms. It does not house the models per se, but
rather links to websites and contacts that can be used to obtain the models.
2) Consequently, there is no verification and validation of models but rather a display of rel-
evant information that allows a user to make an informed decision about the appropriateness
of a model. This is primarily due to the current scope described for the BARD. That is not to
say that this repository of information could not be modeled along the lines of the Biomodels
database and eventually become similar to it. Additionally, we are working towards interlinking
models and metadata within the database and continue to add this functionality as we refine
the content for each model. Such features are already implemented in the BioModels Database.
Epidemiological models are far more diverse than biological models in terms of not only
their scope and range of application, but also their mathematical underpinnings and opera-
tional characteristics like the language they are written in, the platforms they use, the computa-
tional power they require and the data inputs used. This makes building central storehouse of
BARD - A Database for Epidemiological Models
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models all the more difficult and will likely have numerous challenges. However, describing
models and building a repository of model information is a first step towards encouraging the
disease surveillance community towards a way of thinking adopted by members of the biologi-
cal modelling community. This database is the first available system that collects models.
Existing models can range from highly sophisticated data-driven approaches that require
expert training to very simplified models with user-friendly GUIs and no complex computa-
tional requirement. The uniformity that the characterization framework and the BARD offers
for assessing and comparing models gives a wide variety of stakeholders clearer choices and
means to implement models relevant to their situation without having to undertake a lengthy
period of searching via published outputs and websites (when they exist) of these models. For
example, consider a scenario wherein an analyst would like to make projections of how a
malaria outbreak may unfold. For such a scenario, specific information about an operational
model categorized using standardized vocabulary, in a searchable database is more useful than
weeding through thousands of hits obtained by a generic web search for “operational models
for malaria”. In addition, the analyst might be able to apply a usable model and save time dur-
ing an unfolding event rather than having to go through the process of getting together SMEs
to inform a decision that may be needed to quickly mitigate the event.
The BARD offers a way for decision makers to make informed model selections because it
provides information on epidemic modeling features included in the model and the overall
usability of the model in terms of input requirements and computational resources needed in
one location. Additionally, the database allows the user to understand the limitations of each
model and what is required to drive the model. It gives a clear indication of the type of outputs
and thus decision making questions that can be undertaken by each model. A further advance
in this tool could be the use open source ontologies and semantic annotation to refine the
model characterization frameworks and add more detail to model description to enable better
manual model comparison. For example, the epidemiology ontology offered by the Open Bio-
logical and Biomedical Ontologies (OBO) foundry (http://www.obofoundry.org/cgi-bin/detail.
cgi?id=EPO). While not directly related with an epidemiological model, such a resource could
help refine the metadata descriptions of a model such as purpose and scope.
A consensus-driven approach together with the long-term sustainability of a tool like this
does have limitations and challenges. Maintaining stakeholder consensus and communication
is a difficult, but necessary, process in order for this approach to be effective. Additionally,
there are many challenges to practically operating and sustaining a tool like the BARD over
time. To maintain its relevance, BARD content needs to be updated on a regular basis and as a
result, there needs to be some level of continual financial support. One possible way to amelio-
rate the difficulty of these challenges is by operating the BARD and the characterization frame-
work as a community-driven tool whereby the community can update the BARD in much the
same way as a wiki. By allowing users to submit feedback as well as to offer changes or edits to
entries (that would need to be approved by community-chosen editors), costs associated with
maintenance could be significantly lowered while engaging stockholders at the same time. This
opens up many exciting possibilities for community engagement. For example, the usefulness,
efficacy and robustness of a model can only be determined through extensive testing beyond
the research team that developed the model for its own project(s). Therefore, it will useful to
include a user feedback section in the BARD. If the model has already been distributed either
openly or on a limited basis to the infectious disease or public health communities, the BARD’s
responsible official can solicit and moderate comments from the user communities.
With a growing need for mathematical modeling, the effort necessary to evaluate and select
a suitable model for a particular issue can be daunting. The BARD provides a resource to mini-
mize the time and effort, as well as to expand the search for existing models. The tool allows
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decision makers to plan and pre-position models so that they are prepared in the event of need-
ing to use a model for operational response. Prior to or in the face of an outbreak, this can be
invaluable. There have been recent efforts to produce models that can be used by decision mak-
ers not necessarily having expertise in modeling, through the addition of easily accessible user
interfaces and visual aids (e.g., the suite of web-based apps developed by Virginia Bioinformat-
ics Institute, [30]; FRED, [31]; GLEAM, [32]; the Texas Pandemic Flu Toolkit, [33]). However,
without a standardized description of the underlying model and its operational use, there exists
the potential for misuse and misinterpretation of results as well as a lack of confidence in them
[34]. LANL’s model characterization framework and associated web-based model database
offer the first steps towards increasing the acceptance and use of epidemiological models for
infectious disease prediction, forecasting, and assessment.
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